Abdullah Rafi – Page 4 – ARK Foundation

Community Solutions To Antimicrobial Resistance- COSTAR

by

Antimicrobial resistance (AMR) is a major threat to global health, food sustainability and security, and socio-economic development. It is estimated that AMR infections cause approximately 700,000human deaths each year globally, a figure that is set to rise to 10 million by 2050 if no action is taken. COSTAR will build upon these successful foundations by

Published in Antimicrobial Resistance, Our Work

No Comments

Community Dialogues in Bangladesh

by

Community Dialogues in Bangladesh aims to develop and test a “community dialogue” approach for preventing and controlling antibiotic resistance in Bangladesh. It is funded by the Economic and Social Research Council, UK. The project has five objectives: to conduct research to inform the content of and processes for delivering community dialogues; to adapt the

Published in Antimicrobial Resistance, Our Work

No Comments

Children Learning About Second-hand Smoking (CLASS-III)

by

Second-hand smoke (SHS) exposure costs 800,000 lives a year. Children in developing countries are worst affected as smoke-free laws are only partially implemented, and private homes and cars remain a key source of SHS exposure. Children Learning About Second-hand Smoking (CLASS-III) is an ongoing project of ARK Foundation in collaboration with University of York.

Published in Non-Communicable Disease, Our Work

No Comments

Children Learning About Second-hand Smoke (CLASS-II)

by

Children Learning About Second-hand Smoke (CLASS-II) was a two-arm pilot cluster randomised controlled trial funded by the Medical Research Council, UK. The project primarily aimed to establish the effectiveness of a school-based intervention, ‘Smoke Free Homes’ , in reducing exposure of school children to second hand smoke. Its effect on frequency and severity of

Published in Non-Communicable Disease, Our Work

No Comments

Assessing the effectiveness of using Public-Private Partnerships to improve family planning services in Bangladesh

by

Under this study, a public-private partnership (PPP) was developed to help private medical practitioners (PMPs) implement a referral strategy between themselves and family planning centres. We assessed whether the PPP model was effective in increasing the use of long-acting reversible contraceptive methods (LARCMs) and acceptable to both public and private healthcare providers.Our findings revealed

Published in Health Systems, Our Work

No Comments

A mHealth intervention (mTB-Tobacco) for smoking cessation in people with tuberculosis: a two-stage adaptive design, randomized trial (Quit 4 TB Trial)

by

Quit 4 TB Trial project aims to assess in people with TB who smoke daily and check the effectiveness and cost effectiveness of mTB-Tobacco in achieving continuous abstinence for at least six months and also assess the effectiveness and cost effectiveness of mTB-Tobacco in enhancing TB treatment adherence and improving clinical outcomes. We will conduct

Published in Non-Communicable Disease, Our Work

No Comments

Latest Edition of ARK Foundation’s Newsletter

by

We are pleased to announce the release of the latest edition of ARK Foundation Bangladesh’s newsletter. This edition covers the key highlights and activities from the past six months, showcasing our collective achievements and the progress made across various initiatives. The newsletter includes success stories, a summary of our team’s efforts, and highlights of key

Published in Featured, News and Media, Newsletter

No Comments

ARK’s SIMPLE Solution to the Urban Data Dearth

by

By Abdullah Muhammad Rafi On December of 2022, the Government of Bangladesh declared its next major initiative – the Smart Bangladesh Initiative – with a view to building a Smart Nation by 2041. Government’s Aspire to Innovate (a2i) program defines a ‘smart nation’ as “harnessing emerging technologies, networks, and data to create tech-enabled solutions

Published in Blog, Featured

No Comments

Core Outcome Sets for Trials of Interventions to Prevent and to Treat Multimorbidity in Adults in Low and Middle-Income Countries: The COSMOS Study

by

The burden of multimorbidity is recognised increasingly in low- and middle-income countries (LMICs), creating a strong emphasis on the need for effective evidence-based interventions. Core outcome sets (COS) appropriate for the study of multimorbidity in LMICs do not presently exist. These are required to standardise reporting and contribute to a consistent and cohesive evidence-base to